Original language | English (US) |
---|---|
Pages (from-to) | 246-249 |
Number of pages | 4 |
Journal | Leukemia and Lymphoma |
Volume | 60 |
Issue number | 1 |
DOIs | |
State | Published - Jan 2 2019 |
ASJC Scopus subject areas
- Hematology
- Oncology
- Cancer Research
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Leukemia and Lymphoma, Vol. 60, No. 1, 02.01.2019, p. 246-249.
Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - Performance of the Medical Research Council (MRC) and the Leukemia Research Foundation (LRF) score in predicting survival benefit with hypomethylating agent use in patients with relapsed or refractory acute myeloid leukemia
AU - Stahl, Maximilian
AU - DeVeaux, Michelle
AU - Montesinos, Pau
AU - Itzykson, Raphaël
AU - Ritchie, Ellen K.
AU - Sekeres, Mikkael A.
AU - Barnard, John
AU - Podoltsev, Nikolai A.
AU - Brunner, Andrew
AU - Komrokji, Rami S.
AU - Bhatt, Vijaya R.
AU - Al-Kali, Aref
AU - Cluzeau, Thomas
AU - Santini, Valeria
AU - Roboz, Gail J.
AU - Fenaux, Pierre
AU - Litzow, Mark
AU - Fathi, Amir T.
AU - Perreault, Sarah
AU - Kim, Tae Kon
AU - Prebet, Thomas
AU - Vey, Norbert
AU - Verma, Vivek
AU - Germing, Ulrich
AU - Bergua, Juan
AU - Serrano, Josefina
AU - Gore, Steven D.
AU - Zeidan, Amer M.
N1 - Funding Information: The authors acknowledge the Frederick A. DeLuca Foundation for financial support.
PY - 2019/1/2
Y1 - 2019/1/2
UR - http://www.scopus.com/inward/record.url?scp=85049603735&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85049603735&partnerID=8YFLogxK
U2 - 10.1080/10428194.2018.1468893
DO - 10.1080/10428194.2018.1468893
M3 - Letter
C2 - 29963936
AN - SCOPUS:85049603735
SN - 1042-8194
VL - 60
SP - 246
EP - 249
JO - Leukemia and Lymphoma
JF - Leukemia and Lymphoma
IS - 1
ER -